Sanofi India share news, announcements and annual reports

NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap

Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 · Listed Oct 1984 on BSE, May 2003 on NSE

₹3,204.10₹14.60 (0.46%)BSE ₹3,204.40

Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.

30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10

52-week range of traded prices to 30 Oct 2026

₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025

Market cap: ₹7,379 Cr614th largest listed
P/E: 20.24
P/B: 8.93
Dividend yield: 3.84%
ROE: 45.3%
ROCE: 57.3%
Debt to equity: 0.00
Volume, NSE: 2,04,44220.0% delivered

Sanofi India board meetings

108 filed, newest first. Page 1 of 3.

Oct 2026
- 19 Oct · Board meeting
  Board Meeting Intimation for Consideration and Approval of the Unaudited Financial Results for the Quarter and Nine Months ended 30th September 2026; and Declaration and Approval of Interim Dividend, if any, for the Financial Year 2026.
Jul 2026
- 20 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026
Apr 2026
- 20 Apr · Board meeting
  To consider and approve the unaudited financial results for the period ended March 31, 2026
Feb 2026
- 19 Feb · Board meeting
  To consider and approve the Audited Financial Results and Statements for the Quarter and Financial Year ended 31st December 2025 and Recommendation of Final Dividend, if any.
Oct 2025
- 27 Oct · Board meeting
  Outcome of Board Meeting held on October 27, 2025.
- 23 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 and dividend
Jul 2025
- 31 Jul · Board meeting
  Board meeting held on July 31, 2025.
- 18 Jul · Board meeting
  Board Meeting Intimation for consideration and approval of the Unaudited Financial Statements for the quarter and half-year ended 30th June 2025
- 16 Jul · Board meeting
  Outcome of Board Meeting held on July 16, 2025.
May 2025
- 9 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 14th May 2025, inter-alia to consider and approve the Unaudited Financial Statements for the Quarter ended 31st March 2025
Mar 2025
- 18 Mar · Board meeting
  Outcome of the Board meeting held on March 18, 2025.
Feb 2025
- 13 Feb · Board meeting
  To consider and approve the Audited Financial Statements (Standalone & Consolidated) for the Quarter and Financial Year ended 31st December 2024 and Recommendation of Final Dividend, if any.
Oct 2024
- 17 Oct · Board meeting
  Board Meeting Intimation to consider and approve the Unaudited Financial Statements (Standalone & Consolidated) for the quarter and nine months ended 30th September 2024.
Jul 2024
- 26 Jul · Board meeting
  Outcome of Board Meeting held on July 26, 2024.
- 8 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024
May 2024
- 13 May · Board meeting
  Board meeting held on May 13, 2024.
Apr 2024
- 26 Apr · Board meeting
  Board Meeting to be held on 13-May-2024 to consider and approve the financial results for the period ended March 31, 2024
Feb 2024
- 23 Feb · Board meeting
  Outcome of Board Meeting held on February 23, 2024 held for approval of the results and AGM
Jan 2024
- 24 Jan · Board meeting
  To consider and approve the financial results (Standalone and Consolidated) for the Quarter and Financial Year ended December 31, 2023 and recommendation of dividend, if any.
Oct 2023
- 19 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023
Sep 2023
- 26 Sep · Board meeting
  Board meeting held on September 26, 2023 for Change in Director
Aug 2023
- 10 Aug · Board meeting
  We enclose a copy of Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th June 2023 approved at this meeting along with a copy of Limited Review Report. Also enclosed is a copy of Press Release issued in this regard.
Jul 2023
- 26 Jul · Board meeting
  To consider and approve the financial results for the quarter and half year ended Jun 30, 2023
May 2023
- 10 May · Board meeting
  Board meeting held on May 10, 2023.
Apr 2023
- 11 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2023
Feb 2023
- 7 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2022 and dividend.
Nov 2022
- 3 Nov · Board meeting
  Board at its meeting held today i.e.03-Nov-2022 approved the Unaudited Financial Results for the quarter and nine months ended 30th September 2022.
Oct 2022
- 21 Oct · Board meeting
  Board Meeting to be held on 03-Nov-2022 to consider financial statements for the period ended September 2022.Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Thursday, 3rd November 2022; inter alia to consider the unaudited financial results for the quarter and nine months ended 30th September 2022.Further, to our intimation on 30th September 2022, this is to inform you that as per the "Sanofi India Limited - Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the trading window of the Company, which was closed from 1st October 2022, for publication of financial results of the Company for the quarter and nine months ended 30th September 2022 shall remain closed up to Saturday, 5th November 2022 (inclusive of both days).
Jul 2022
- 26 Jul · Board meeting
  We refer to our letter dated 6th July 2022 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 02.00 p.m. and concluded at 5.10 p.m. The Board approved unaudited financial results for the quarter and half year ended 30th June 2022.Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the unaudited financial results for the quarter and half year ended 30th June 2022 approved at this Meeting including the Statement of Assets and Liabilities as on that date and the Statement of Cash Flow for the half year ended 30th June 2022 along with a copy of the Limited Review Report duly signed by the Auditors of the Company.
- 6 Jul · Board meeting
  Board Meeting to be held on 26-Jul-2022 to consider financial statements for the period ended June 2022
Apr 2022
- 7 Apr · Board meeting
  Board Meeting to be held on 26-Apr-2022 to consider financial statements for the period ended March 2022
Feb 2022
- 23 Feb · Board meeting
  Board Meeting held on 23-Feb-2022 to consider financial statements for the period ended December 2021 and Dividend
- 7 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021 and dividend
Oct 2021
- 13 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021
Jul 2021
- 12 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021
Apr 2021
- 27 Apr · Board meeting
  Board meeting held on April 27, 2021.
- 14 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2021
Feb 2021
- 8 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020 and dividend.
Oct 2020
- 27 Oct · Board meeting
  Board meeting held on October 27, 2020.
- 13 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 27th October 2020; inter alia to consider the unaudited financial results for the quarter and nine months ended 30th September 2020 (Q3).
Jul 2020
- 15 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020
May 2020
- 12 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020
Feb 2020
- 5 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019 and dividend
Nov 2019
- 12 Nov · Board meeting
  Board meeting held on November 12, 2019.
Oct 2019
- 31 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2019
Sep 2019
- 11 Sep · Board meeting
  Board meeting held on September 10, 2019.The Board of Directors of Sanofi India Limited (the Company) at its meeting held on 10th September 2019 approved a transaction for the slump sale and transfer of the manufacturing facility of the Company at Ankleshwar, Gujarat to Zentiva Private Limited for a consideration of Rs. 2,617 million, subject to customary working capital adjustments. This transaction is subject to approval of the members, which will be initiated by the Company through a postal ballot process and few other conditions as defined under the Business Transfer Agreement.
Jul 2019
- 29 Jul · Board meeting
  Outcome of Board Meeting held on July 29, 2019.
- 15 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019
May 2019
- 7 May · Board meeting
  Board meeting held on May 07, 2019.
Apr 2019
- 22 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019

Sanofi India board meetings

Oct 2026

Jul 2026

Apr 2026

Feb 2026

Oct 2025

Jul 2025

May 2025

Mar 2025

Feb 2025

Oct 2024

Jul 2024

May 2024

Apr 2024

Feb 2024

Jan 2024

Oct 2023

Sep 2023

Aug 2023

Jul 2023

May 2023

Apr 2023

Feb 2023

Nov 2022

Oct 2022

Jul 2022

Apr 2022

Feb 2022

Oct 2021

Jul 2021

Apr 2021

Feb 2021

Oct 2020

Jul 2020

May 2020

Feb 2020

Nov 2019

Oct 2019

Sep 2019

Jul 2019

May 2019

Apr 2019